Apogee Therapeutics APGE

Monthly Leaders · June 2026 · Updated July 18, 2026

Health CareNews Spike

Setup Snapshot

The Setup in One Card

How APGE scored, how it moved against the market, and the catalyst behind the move. A high score means the stock deserves research time, not that it is a buy.

Friday Five Score

June 2026 Return

APGE+61.59%

June 2026

+61.59% · Rank 1

Sector Trend

Neutral-0.23%

Actionability

News Spike

Catalyst

Acquisition

Takeout agreement at $135 per share in cash

Returns are measured from the Thursday, July 9 close to the Thursday, July 16 close. Benchmarks: S&P 500 -0.1% and Nasdaq Composite -1.2% for the week. Benchmark figures are official index closes; sector figures use SPDR sector ETF closes because the official S&P sector index closes for this window were not yet published at press time.

← Back to the full scoreboard

This page is for educational and informational purposes only. It is not financial advice, investment advice, or a recommendation to buy or sell any security.